Skip To Main Content

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

Beyfortus® ▼(nirsevimab): effectiveness and public health impact in the real world

Gaucher disease in children

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, resulting in deficient activity of the enzyme acid β glucosidase.

Real-World Evidence and Phase IV studies in CRSwNP

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life (QoL), often requiring recurring systemic corticosteroid use and repeated sinus surgery.

DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP

The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

IL-4 and IL-13: centrale cytokines die type 2-inflammatie aansturen

Understanding Gaucher Disease: Symptoms, Classification, and Clinical Presentation

Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.1